Mabpharm Limited (02181.HK) Stock Price, Chart, News and AI analysis

Q: What is the price performance of MABPHARM-B stock?

The current price of MABPHARM-B is $0.51, it has increased 2% in the last trading day.

Q: What are the primary business themes or industries for Mabpharm Limited?

Mabpharm Limited belongs to Biotechnology industry and the sector is Health Care

Q: What is Mabpharm Limited market cap?

Mabpharm Limited's current market cap is $2.1B

Home

Stock

02181.HK

MABPHARM-B (02181.HK)

Mabpharm Limited

HK$0.51

2%

$0.01

CLOSED_MARKET: Jan 16, 16:00:00 HKT

Key Stats

Prev.Close

$0.52

Open

$0.5

Day's Range

$0.5 - $0.51

52 week range

$0.25 - $0.94

Volume

12.0K

Avg.Volume

88.2K

EPS (TTM)

-0.01

Dividend yield

Market Cap

$2.1B

What is MABPHARM-B?

Mabpharm Ltd. engages in the research, development, and manufacture of monoclonal antibody drugs for the treatment of cancer and autoimmune diseases. The company is headquartered in Taizhou, Jiangsu and currently employs 383 full-time employees. The company went IPO on 2019-05-31. The Company’s main products include CMAB009 Enlituo (cetuximab β injection), CMAB007 Aomaishu (Omalizumab α for Injection), CMAB008 Leiting (infliximab for injection) and other products. The Company’s products are mainly used for colorectal cancer, asthma, urticaria, rheumatoid arthritis, ulcerative colitis in adults and other diseases. The firm is also engaged in the transfer of intellectual property. The firm mainly conducts its business in the domestic market.



Features

AI Copilot for Stock & Crypto

Trading Strategies

Megabrain Investors Picks

Trading Mindshare